Morgan Stanley Adma Biologics, Inc. Put Options Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
320Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$354 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$344 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$247 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$240 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL6.58MShares$125 Million0.04% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.73B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...